Christine Bohmann, PhD, is the Global Head of IP at Alcon, where they have been instrumental in leading IP strategy since 2019. They previously served as Head IP Animal Health at Novartis from 2009 to 2013 and held various roles in Consumer Health and Pharma Patents. Christine also contributed as Head of Pharma Patents at Alcon for a brief period in 2013. They hold a Diploma in European Patent Litigation from the University of Strasbourg, completed in 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices